[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Original Article
October 4, 2010October 2010

Attention-Deficit/Hyperactivity Disorder Symptoms in Offspring of Mothers With Impaired Serotonin Production

Author Affiliations

Author Affiliations: Departments of Biomedicine (Drs Halmøy, Johansson, Winge, McKinney, and Haavik) and Clinical Medicine (Dr Knappskog), University of Bergen, and Center of Medical Genetics and Molecular Medicine (Drs Johansson and Knappskog) and Division of Psychiatry (Dr Haavik), Haukeland University Hospital, Bergen, Norway.

Arch Gen Psychiatry. 2010;67(10):1033-1043. doi:

Context  Exposure to adverse events during prenatal and postnatal development, as well as serotonin deficiency, have been implicated in disturbances of mood and impulsivity, but the underlying mechanisms are unknown.

Objective  To investigate the long-term effects of an impaired serotonin synthesis on the developing human brain, we studied the effects of nonsynonymous mutations affecting tryptophan hydroxylase (TPH) enzymes responsible for serotonin production in maternal reproductive tissues (TPH1) and the brain (TPH2).

Design  Family-based case-control and functional studies of candidate genes.

Setting  Adult outpatients with attention-deficit/hyperactivity disorder (ADHD), their family members, and random control subjects were recruited across Norway.

Participants  Nine pedigrees with TPH1 and TPH2 mutation carriers were identified among 459 patients with ADHD and 187 controls. The TPH genes were then sequenced in 97 additional family members, and information about psychiatric diagnoses and symptoms was obtained from 606 controls, the 459 patients, and their relatives.

Main Outcome Measures  The effects of maternal vs paternal TPH1 mutations compared in all families.

Results  Nine different TPH1 and TPH2 mutations were found by sequencing in 646 individuals (1.0% and 0.2% allele frequency, respectively). In vitro studies showed that 8 TPH mutants had significantly impaired enzyme function. Family analysis of 38 TPH1 mutation carriers and 41 of their offspring revealed that offspring of mothers carrying TPH1 mutations reported 1.5- to 2.5-times-higher ADHD scores and related symptoms during childhood and as adults than did controls (P < 10−6) or offspring of fathers with the corresponding TPH1 mutations (P < .001).

Conclusions  Impaired maternal serotonin production may have long-term consequences for brain development and increase the risk of ADHD-related symptoms and behavior in offspring. Replication studies are required to form conclusions about the clinical implications of mutations affecting serotonin biosynthesis.